Counterfeit medicines in Peru: a retrospective review (1997–2014)

ObjectiveTo consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997–2014) of health monitoring and enforcement.DesignA retrospective review of drug alerts.SettingA search of the website of...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 6; no. 4; p. e010387
Main Authors Medina, Edwin, Bel, Elvira, Suñé, Josep María
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 04.04.2016
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Alerts
counterfeit
Counterfeit Drugs
Counterfeiting
Drug dosages
Drug stores
Drugs
Falsified
Fraud - trends
Humans
Laboratories
Medical equipment
Medicine
Medicines
Peru
Pharmaceuticals
Public Health
Registration
Retrospective Studies
Safety
United States > US
Peru
Drugs
Alerts
Safety
Medicines
counterfeit
Falsified
Online AccessGet full text

Cover

Abstract ObjectiveTo consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997–2014) of health monitoring and enforcement.DesignA retrospective review of drug alerts.SettingA search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014.Eligibility criteriaDrug alerts related to counterfeit medicines.ResultsA total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified.ConclusionsCounterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.
AbstractList Objective To consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997–2014) of health monitoring and enforcement.Design A retrospective review of drug alerts.Setting A search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014.Eligibility criteria Drug alerts related to counterfeit medicines.Results A total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified.Conclusions Counterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.
To consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997-2014) of health monitoring and enforcement.OBJECTIVETo consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997-2014) of health monitoring and enforcement.A retrospective review of drug alerts.DESIGNA retrospective review of drug alerts.A search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014.SETTINGA search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014.Drug alerts related to counterfeit medicines.ELIGIBILITY CRITERIADrug alerts related to counterfeit medicines.A total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified.RESULTSA total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified.Counterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.CONCLUSIONSCounterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.
ObjectiveTo consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997–2014) of health monitoring and enforcement.DesignA retrospective review of drug alerts.SettingA search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014.Eligibility criteriaDrug alerts related to counterfeit medicines.ResultsA total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified.ConclusionsCounterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.
To consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18 years (1997-2014) of health monitoring and enforcement. A retrospective review of drug alerts. A search of the website of the General Directorate of Medicines, Supplies and Drugs (DIGEMID) of the Ministry of Health of Peru for drug alerts issued between 1997 and 2014. Drug alerts related to counterfeit medicines. A total of 669 DIGEMID alerts were issued during the study period, 354 (52.91%) of which cover 1738 cases of counterfeit medicines (many alerts deal with several cases at a time). 1010 cases (58.11%) involved pharmaceutical establishments and 349 (20.08%) involved non-pharmaceutical commercial outlets. In 126 cases (7.25%), counterfeit medicines were seized in an unauthorised trade (without any marketing authorisation); in 253 cases (14.56%) the type of establishment or business associated with the seized product was not identified. Counterfeit medicines are a serious public health problem in Peru. A review of the data cannot determine whether counterfeit medicines in Peru increased during the study period, or if monitoring by different government health agencies highlighted the magnitude of the problem by providing more evidence. The problem is clearly structural, since the majority of cases (58.11% of the total) were detected in legitimate supply chains. Most counterfeit medicines involve staple pharmaceutical products and common dosage forms. Considerable work remains to be done to control the serious problem of counterfeit medicines in Peru.
Author Bel, Elvira
Suñé, Josep María
Medina, Edwin
AuthorAffiliation Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
AuthorAffiliation_xml – name: Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of Barcelona , Barcelona , Spain
Author_xml – sequence: 1
  givenname: Edwin
  surname: Medina
  fullname: Medina, Edwin
– sequence: 2
  givenname: Elvira
  surname: Bel
  fullname: Bel, Elvira
– sequence: 3
  givenname: Josep María
  surname: Suñé
  fullname: Suñé, Josep María
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27044580$$D View this record in MEDLINE/PubMed
BookMark eNqNUstuFDEQtFAQCSFfgIRG4hIOk_g19phDJLTiESkSHOBs2Z6e4NWsvXg8i7jxD_nDfAleZhOSHCJ8sdtdVe5213O0F2IAhF4SfEIIE6d2tYxrCDXFpKkxwayVT9ABxZzXAjfN3p3zPjoaxyUuizeqaegztE9lSTYtPkCLRZxChtSDz9UKOu98gLHyofoCaXpbmSpBTnFcg8t-AyXaePhZHROl5PXvq_I8f_MCPe3NMMLRbj9E3z68_7r4VF98_ni-eHdR20a2ubaGUa6s4LZxVgjb9IRY0jKphLXS0l70fU-do1JYAEG7nhhgrgSSWtk5dojOZ90umqVeJ78y6ZeOxuu_FzFdapOydwNo3smOQ0eBCMe7tmupwMoRZhW1wihctM5mrfVkS9sOQk5muCd6PxP8d30ZN5q3lHFGi8DxTiDFHxOMWa_86GAYTIA4jZpIqTAlRPECff0AuoxTCuWrNBWClXlixgrq1d2Kbku5mVUBqBngyjzGBL12Ppvs47ZAP2iC9dYaemcNvbWGnq1RuOwB90b-cdbJzCrJ_ySc_iPcNvkY4w9jDNuL
CitedBy_id crossref_primary_10_1007_s10858_020_00318_w
crossref_primary_10_1364_AOP_9_000218
crossref_primary_10_1111_jphs_12207
crossref_primary_10_1590_0102_311x00065118
crossref_primary_10_1080_17441692_2020_1744678
crossref_primary_10_1186_s40545_016_0088_0
crossref_primary_10_1016_j_addr_2021_114098
crossref_primary_10_1016_j_tmaid_2024_102758
crossref_primary_10_1038_s41598_017_05892_y
crossref_primary_10_1002_pds_4785
crossref_primary_10_1136_bmjgh_2018_000771
crossref_primary_10_1016_j_jsps_2017_10_011
crossref_primary_10_1186_s40545_020_00208_4
crossref_primary_10_3389_fpls_2019_00987
Cites_doi 10.5588/ijtld.12.0988
10.1136/bmj.f2732
10.1186/1744-8603-9-45
10.1093/chromsci/bmt006
10.3797/scipharm.1202-03
10.1016/j.chroma.2011.05.102
10.1111/bcp.12298
10.2471/BLT.10.020410
10.4103/0975-7406.111820
10.1186/1741-7015-11-233
10.1038/embor.2013.82
10.1016/j.jpba.2013.01.009
10.1007/s10916-014-0141-y
10.4269/ajtmh.13-0644
10.1016/j.chroma.2014.03.078
10.1371/journal.pone.0090601
10.1016/j.jpba.2013.05.004
10.2174/1574886311308010007
10.1016/j.talanta.2011.07.022
10.12809/hkmj133841
10.1136/bmjopen-2014-006088
10.1016/j.aca.2011.05.041
10.1016/S2214-109X(14)70279-7
10.1136/bmjopen-2013-002924
10.1016/j.chroma.2012.09.038
10.1016/j.talanta.2014.01.020
10.1331/JAPhA.2012.11085
10.1136/bmj.e7381
10.1186/2050-6511-15-34
10.1179/204777312X13419245939485
10.1016/j.talanta.2014.05.050
10.17226/18272
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9-
K9.
KB0
M0R
M0S
M1P
M2M
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1136/bmjopen-2015-010387
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Family Health
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: Proquest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2044-6055
ExternalDocumentID oai_doaj_org_article_4d7d4ed2e16c4d8d82609c13b92b6a90
PMC4823432
27044580
10_1136_bmjopen_2015_010387
bmjopen
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
Peru
GeographicLocations_xml – name: United States--US
– name: Peru
GroupedDBID ---
4.4
53G
5VS
7RV
7X7
7~R
88E
8FI
8FJ
9YT
ABUWG
ACGFS
ACMMV
ADBBV
ADRAZ
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKNYI
BPHCQ
BTFSW
BTHHO
CCPQU
DIK
DWQXO
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
HZ~
K9-
KQ8
M0R
M1P
M2M
M48
M~E
NAPCQ
O9-
OK1
PGMZT
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
RHI
RMJ
RPM
UKHRP
BVXVI
AAYXX
CITATION
PHGZM
3V.
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-b578t-ba3249b64b5cb66b5f11b183796bb7b2f6fff2cc276bee62df1ae3c6be72b7dc3
IEDL.DBID 9YT
ISSN 2044-6055
IngestDate Wed Aug 27 01:31:40 EDT 2025
Thu Aug 21 18:15:03 EDT 2025
Fri Jul 11 01:34:29 EDT 2025
Sat Jul 26 00:24:51 EDT 2025
Thu Jan 02 22:41:42 EST 2025
Tue Jul 01 04:08:12 EDT 2025
Thu Apr 24 23:01:28 EDT 2025
Thu Apr 24 23:02:46 EDT 2025
Thu Apr 24 22:49:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Drugs
Alerts
Safety
Medicines
counterfeit
Falsified
Language English
License This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b578t-ba3249b64b5cb66b5f11b183796bb7b2f6fff2cc276bee62df1ae3c6be72b7dc3
Notes Research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://dx.doi.org/10.1136/bmjopen-2015-010387
PMID 27044580
PQID 2663113033
PQPubID 2040975
ParticipantIDs doaj_primary_oai_doaj_org_article_4d7d4ed2e16c4d8d82609c13b92b6a90
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4823432
proquest_miscellaneous_1779021194
proquest_journals_2663113033
pubmed_primary_27044580
crossref_citationtrail_10_1136_bmjopen_2015_010387
crossref_primary_10_1136_bmjopen_2015_010387
bmj_primary_10_1136_bmjopen_2015_010387
bmj_journals_10_1136_bmjopen_2015_010387
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20160404
PublicationDateYYYYMMDD 2016-04-04
PublicationDate_xml – month: 4
  year: 2016
  text: 20160404
  day: 4
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationTitle BMJ open
PublicationTitleAbbrev BMJ Open
PublicationTitleAlternate BMJ Open
PublicationYear 2016
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Benton, Williamson, Stodart (R50) 2014; 20
Lai, Chan (R55) 2013; 19
Gostin, Carpenter, Hogerzeil (R56)
(R5) 2010; 88
Dégardin, Roggo, Margot (R4) 2014; 87
Deconinck, Sacré, Courselle (R47) 2013; 51
Mbinze, Lebrun, Debrus (R48) 2012; 1263
Ranieri, Tabernero, Green (R41) 2014; 91
Johnston, Holt (R14) 2014; 78
Bansal, Malla, Gudala (R36) 2013; 81
Koesdjojo, Wu, Boonloed (R42) 2014; 130
Chambliss, Carroll, Kennedy (R28) 2012; 52
Custers, Canfyn, Courselle (R44) 2014; 123
Mackey, Liang (R57) 2013; 11
Pullirsch, Bellemare, Hackl (R13) 2014; 15
Bussy, Thibaudeau, Thomas (R38) 2011; 85
Sacré, Deconinck, Daszykowski (R39) 2011; 701
Anzanello, Ortiz, Limbergerb (R45) 2013; 83
Weigmann (R58) 2013; 14
Almuzaini, Sammons, Choonara (R25) 2013; 3
Taylor (R35) 2014; 38
Seear (R59) 2013; 17
Tremblay (R53) 2013; 8
Attaran, Barry, Basheer (R60) 2012; 345
McCarthy (R46) 2013; 346
Kovacs, Hawes, Maley (R34) 2014; 9
Mackey, Liang (R51) 2013; 9
(R10) 2009; 26
Almuzaini, Sammons, Choonara (R26) 2014; 4
Hall (R37) 2012; 106
Lebel, Gagnon, Furtos (R43) 2014; 1343
Nityanand Zadbuke, Sadhana (R40) 2013; 5
Newton, Tabernero, Dwivedi (R61) 2014; 2
Blackstone, Fuhr, Pociask (R7) 2014; 7
Debrus, Lebrun, Kindenge (R49) 2011; 1218
Bansal, Malla, Gudala 2013; 81
Seear 2013; 17
Custers, Canfyn, Courselle 2014; 123
Mackey, Liang 2013; 9
Lai, Chan 2013; 19
Ranieri, Tabernero, Green 2014; 91
Taylor 2014; 38
Nityanand Zadbuke, Sadhana 2013; 5
Anzanello, Ortiz, Limbergerb 2013; 83
Lebel, Gagnon, Furtos 2014; 1343
Newton, Tabernero, Dwivedi 2014; 2
Johnston, Holt 2014; 78
Tremblay 2013; 8
Attaran, Barry, Basheer 2012; 345
Bussy, Thibaudeau, Thomas 2011; 85
Gostin, Carpenter, Hogerzeil
Blackstone, Fuhr, Pociask 2014; 7
Deconinck, Sacré, Courselle 2013; 51
Chambliss, Carroll, Kennedy 2012; 52
Dégardin, Roggo, Margot 2014; 87
Almuzaini, Sammons, Choonara 2014; 4
Kovacs, Hawes, Maley 2014; 9
2009; 26
Koesdjojo, Wu, Boonloed 2014; 130
2010; 88
Weigmann 2013; 14
McCarthy 2013; 346
Sacré, Deconinck, Daszykowski 2011; 701
Hall 2012; 106
Mackey, Liang 2013; 11
Debrus, Lebrun, Kindenge 2011; 1218
Benton, Williamson, Stodart 2014; 20
Pullirsch, Bellemare, Hackl 2014; 15
Meza-Cornejo 2010
Almuzaini, Sammons, Choonara 2013; 3
Mbinze, Lebrun, Debrus 2012; 1263
2024051515233018000_6.4.e010387.60
2024051515233018000_6.4.e010387.61
2024051515233018000_6.4.e010387.20
2024051515233018000_6.4.e010387.21
Bussy (2024051515233018000_6.4.e010387.38) 2011; 85
2024051515233018000_6.4.e010387.22
2024051515233018000_6.4.e010387.23
2024051515233018000_6.4.e010387.24
2024051515233018000_6.4.e010387.26
2024051515233018000_6.4.e010387.9
2024051515233018000_6.4.e010387.27
2024051515233018000_6.4.e010387.18
2024051515233018000_6.4.e010387.19
(2024051515233018000_6.4.e010387.10) 2009; 26
Chambliss (2024051515233018000_6.4.e010387.28) 2012; 52
2024051515233018000_6.4.e010387.51
2024051515233018000_6.4.e010387.52
2024051515233018000_6.4.e010387.53
2024051515233018000_6.4.e010387.54
2024051515233018000_6.4.e010387.11
Almuzaini (2024051515233018000_6.4.e010387.25) 2013; 3
2024051515233018000_6.4.e010387.12
2024051515233018000_6.4.e010387.56
2024051515233018000_6.4.e010387.57
2024051515233018000_6.4.e010387.14
2024051515233018000_6.4.e010387.58
2024051515233018000_6.4.e010387.15
2024051515233018000_6.4.e010387.16
2024051515233018000_6.4.e010387.17
Bansal (2024051515233018000_6.4.e010387.36) 2013; 81
2024051515233018000_6.4.e010387.8
2024051515233018000_6.4.e010387.6
Benton (2024051515233018000_6.4.e010387.50) 2014; 20
2024051515233018000_6.4.e010387.3
2024051515233018000_6.4.e010387.4
2024051515233018000_6.4.e010387.1
2024051515233018000_6.4.e010387.2
Lebel (2024051515233018000_6.4.e010387.43) 2014; 1343
Nityanand Zadbuke (2024051515233018000_6.4.e010387.40) 2013; 5
Seear (2024051515233018000_6.4.e010387.59) 2013; 17
World Health Organization (2024051515233018000_6.4.e010387.5) 2010; 88
2024051515233018000_6.4.e010387.41
2024051515233018000_6.4.e010387.42
Lai (2024051515233018000_6.4.e010387.55) 2013; 19
Custers (2024051515233018000_6.4.e010387.44) 2014; 123
2024051515233018000_6.4.e010387.46
2024051515233018000_6.4.e010387.47
2024051515233018000_6.4.e010387.48
2024051515233018000_6.4.e010387.49
Anzanello (2024051515233018000_6.4.e010387.45) 2013; 83
Hall (2024051515233018000_6.4.e010387.37) 2012; 106
2024051515233018000_6.4.e010387.30
2024051515233018000_6.4.e010387.31
2024051515233018000_6.4.e010387.32
2024051515233018000_6.4.e010387.33
2024051515233018000_6.4.e010387.34
2024051515233018000_6.4.e010387.39
2024051515233018000_6.4.e010387.29
Pullirsch (2024051515233018000_6.4.e010387.13) 2014; 15
Blackstone (2024051515233018000_6.4.e010387.7) 2014; 7
Taylor (2024051515233018000_6.4.e010387.35) 2014; 38
References_xml – volume: 17
  start-page: 286
  year: 2013
  ident: R59
  article-title: The need for coordinated action against falsified and substandard medicines
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.12.0988
– volume: 346
  start-page: f2732
  year: 2013
  ident: R46
  article-title: Handheld device for counterfeit drug detection to be tested in Africa
  publication-title: BMJ
  doi: 10.1136/bmj.f2732
– volume: 20
  start-page: 27
  year: 2014
  ident: R50
  article-title: Buying medicine online is risky business
  publication-title: Nurs N Z
– volume: 9
  start-page: 45
  year: 2013
  ident: R51
  article-title: Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
  publication-title: Global Health
  doi: 10.1186/1744-8603-9-45
– ident: R56
  article-title: IOM (Institute of Medicine). Countering the problem of falsified and substandard drugs. Washington, DC: The National Academies Press, 2013
– volume: 51
  start-page: 791
  year: 2013
  ident: R47
  article-title: Chromatography in the detection and characterization of illegal pharmaceutical preparations
  publication-title: J Chromatogr Sci
  doi: 10.1093/chromsci/bmt006
– volume: 81
  start-page: 1
  year: 2013
  ident: R36
  article-title: Anti-counterfeit technologies: a pharmaceutical industry perspective
  publication-title: Sci Pharm
  doi: 10.3797/scipharm.1202-03
– volume: 1218
  start-page: 5205
  year: 2011
  ident: R49
  article-title: Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2011.05.102
– volume: 78
  start-page: 218
  year: 2014
  ident: R14
  article-title: Substandard drugs: a potential crisis for public health
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/bcp.12298
– volume: 88
  start-page: 247
  year: 2010
  ident: R5
  article-title: Growing threat from counterfeit medicines
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.10.020410
– volume: 7
  start-page: 216
  year: 2014
  ident: R7
  article-title: The health and economic effects of counterfeit drugs
  publication-title: Am Health Drug Benefits
– volume: 5
  start-page: 98
  year: 2013
  ident: R40
  article-title: Recent trends and future of pharmaceutical packaging technology
  publication-title: J Pharm Bioallied Sci
  doi: 10.4103/0975-7406.111820
– volume: 11
  start-page: 233
  year: 2013
  ident: R57
  article-title: Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
  publication-title: BMC Med
  doi: 10.1186/1741-7015-11-233
– volume: 14
  start-page: 597
  year: 2013
  ident: R58
  article-title: Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated
  publication-title: EMBO Rep
  doi: 10.1038/embor.2013.82
– volume: 87
  start-page: 167
  year: 2014
  ident: R4
  article-title: Understanding and fighting the medicine counterfeit market
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2013.01.009
– volume: 38
  start-page: 141
  year: 2014
  ident: R35
  article-title: RFID in the pharmaceutical industry: addressing counterfeits with technology
  publication-title: J Med Syst
  doi: 10.1007/s10916-014-0141-y
– volume: 91
  start-page: 920
  year: 2014
  ident: R41
  article-title: Evaluation of a new handheld instrument for the detection of counterfeit artesunate by visual fluorescence comparison
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.13-0644
– volume: 1343
  start-page: 143
  year: 2014
  ident: R43
  article-title: A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2014.03.078
– volume: 9
  start-page: e90601
  year: 2014
  ident: R34
  article-title: Technologies for detecting falsified and substandard drugs in low and middle-income countries
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0090601
– volume: 83
  start-page: 209
  year: 2013
  ident: R45
  article-title: A multivariate-based wavenumber selection method for classifying medicines into authentic or counterfeitclasses
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2013.05.004
– volume: 8
  start-page: 43
  year: 2013
  ident: R53
  article-title: Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain
  publication-title: Curr Drug Saf
  doi: 10.2174/1574886311308010007
– volume: 85
  start-page: 1909
  year: 2011
  ident: R38
  article-title: Isotopic finger-printing of active pharmaceutical ingredients by 13C NMR and polarization transfer techniques as a tool to fight against counterfeiting
  publication-title: Talanta
  doi: 10.1016/j.talanta.2011.07.022
– volume: 19
  start-page: 286
  year: 2013
  ident: R55
  article-title: Legislations combating counterfeit drugs in Hong Kong
  publication-title: Hong Kong Med J
  doi: 10.12809/hkmj133841
– volume: 4
  start-page: e006088
  year: 2014
  ident: R26
  article-title: Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-006088
– volume: 26
  start-page: 517
  year: 2009
  ident: R10
  article-title: Simposio: Política de Medicamentos. LEY N.° 29459—ley de los productos farmacéuticos, dispositivos médicos y productos sanitarios
  publication-title: Rev Peru Med Exp Salud Pública
– volume: 701
  start-page: 224
  year: 2011
  ident: R39
  article-title: Impurity fingerprints for the identification of counterfeit medicines--a feasibility study
  publication-title: Anal Chim Acta
  doi: 10.1016/j.aca.2011.05.041
– volume: 2
  start-page: e509
  year: 2014
  ident: R61
  article-title: Falsified medicines in Africa: all talk, no action
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(14)70279-7
– volume: 3
  start-page: pii: e002924
  year: 2013
  ident: R25
  article-title: Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-002924
– volume: 1263
  start-page: 113
  year: 2012
  ident: R48
  article-title: Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2012.09.038
– volume: 123
  start-page: 78
  year: 2014
  ident: R44
  article-title: Headspace-gas chromatographic fingerprints to discriminate and classify counterfeit medicines
  publication-title: Talanta
  doi: 10.1016/j.talanta.2014.01.020
– volume: 52
  start-page: 195
  year: 2012
  ident: R28
  article-title: Role of the pharmacist in preventing distribution of counterfeit medications
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2012.11085
– volume: 345
  start-page: e7381
  year: 2012
  ident: R60
  article-title: How to achieve international action on falsified and substandard medicines
  publication-title: BMJ
  doi: 10.1136/bmj.e7381
– volume: 15
  start-page: 34
  year: 2014
  ident: R13
  article-title: Microbiological contamination in counterfeit and unapproved drugs
  publication-title: BMC Pharmacol Toxicol
  doi: 10.1186/2050-6511-15-34
– volume: 106
  start-page: 73
  year: 2012
  ident: R37
  article-title: Technology for combating counterfeit medicine
  publication-title: Pathog Glob Health
  doi: 10.1179/204777312X13419245939485
– volume: 130
  start-page: 122
  year: 2014
  ident: R42
  article-title: Low-cost, high-speed identification of counterfeit antimalarial drugs on paper
  publication-title: Talanta
  doi: 10.1016/j.talanta.2014.05.050
– volume: 4
  start-page: e006088
  year: 2014
  article-title: Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-006088
– article-title: del 09 Junio de 2015
– volume: 91
  start-page: 920
  year: 2014
  article-title: Evaluation of a new handheld instrument for the detection of counterfeit artesunate by visual fluorescence comparison
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.13-0644
– article-title: ganización y Funciones de las Direcciones de Salud y de las Direcciones de Red de Salud
– volume: 52
  start-page: 195
  year: 2012
  article-title: Role of the pharmacist in preventing distribution of counterfeit medications
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2012.11085
– article-title: GEMID del 26 de mayo de 1998
– volume: 38
  start-page: 141
  year: 2014
  article-title: RFID in the pharmaceutical industry: addressing counterfeits with technology
  publication-title: J Med Syst
  doi: 10.1007/s10916-014-0141-y
– volume: 1218
  start-page: 5205
  year: 2011
  article-title: Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2011.05.102
– article-title: a en el Perú Enero—Febrero—Marzo 2014
– article-title: Medicamentos espurios, de etiquetado engañoso, falsificados o de imitación. Nota descriptiva N°275
– volume: 1343
  start-page: 143
  year: 2014
  article-title: A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2014.03.078
– article-title: 84 del 16 de abril de 1990, Ley de Organización y Funciones del Ministerio de Salud
– volume: 51
  start-page: 791
  year: 2013
  article-title: Chromatography in the detection and characterization of illegal pharmaceutical preparations
  publication-title: J Chromatogr Sci
  doi: 10.1093/chromsci/bmt006
– volume: 87
  start-page: 167
  year: 2014
  article-title: Understanding and fighting the medicine counterfeit market
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2013.01.009
– volume: 3
  start-page: pii: e002924
  year: 2013
  article-title: Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-002924
– volume: 1263
  start-page: 113
  year: 2012
  article-title: Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2012.09.038
– year: 2010
  article-title: Valor terapéutico de los medicamentos más vendidos en el Perú
– volume: 123
  start-page: 78
  year: 2014
  article-title: Headspace-gas chromatographic fingerprints to discriminate and classify counterfeit medicines
  publication-title: Talanta
  doi: 10.1016/j.talanta.2014.01.020
– volume: 346
  start-page: f2732
  year: 2013
  article-title: Handheld device for counterfeit drug detection to be tested in Africa
  publication-title: BMJ
  doi: 10.1136/bmj.f2732
– volume: 19
  start-page: 286
  year: 2013
  article-title: Legislations combating counterfeit drugs in Hong Kong
  publication-title: Hong Kong Med J
  doi: 10.12809/hkmj133841
– volume: 78
  start-page: 218
  year: 2014
  article-title: Substandard drugs: a potential crisis for public health
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/bcp.12298
– volume: 11
  start-page: 233
  year: 2013
  article-title: Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
  publication-title: BMC Med
  doi: 10.1186/1741-7015-11-233
– article-title: Population in 2000 to 2015
– article-title: ra el Registro, Control y Vigilncia Sanitaria de Productos Farmacéuticos, Dispositivos Médico y Productos Sanitarios
– volume: 5
  start-page: 98
  year: 2013
  article-title: Recent trends and future of pharmaceutical packaging technology
  publication-title: J Pharm Bioallied Sci
  doi: 10.4103/0975-7406.111820
– article-title: gionales y Subregionales de Salud asuman las funciones de control y vigilancia de los productos farmacéuticos y afines
– volume: 81
  start-page: 1
  year: 2013
  article-title: Anti-counterfeit technologies: a pharmaceutical industry perspective
  publication-title: Sci Pharm
  doi: 10.3797/scipharm.1202-03
– volume: 106
  start-page: 73
  year: 2012
  article-title: Technology for combating counterfeit medicine
  publication-title: Pathog Glob Health
  doi: 10.1179/204777312X13419245939485
– volume: 2
  start-page: e509
  year: 2014
  article-title: Falsified medicines in Africa: all talk, no action
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(14)70279-7
– article-title: Registro Nacional de Establecimientos Farmacéuticos
– volume: 83
  start-page: 209
  year: 2013
  article-title: A multivariate-based wavenumber selection method for classifying medicines into authentic or counterfeitclasses
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2013.05.004
– volume: 20
  start-page: 27
  year: 2014
  article-title: Buying medicine online is risky business
  publication-title: Nurs N Z
– article-title: IOM (Institute of Medicine). Countering the problem of falsified and substandard drugs. Washington, DC: The National Academies Press, 2013
– volume: 85
  start-page: 1909
  year: 2011
  article-title: Isotopic finger-printing of active pharmaceutical ingredients by 13C NMR and polarization transfer techniques as a tool to fight against counterfeiting
  publication-title: Talanta
  doi: 10.1016/j.talanta.2011.07.022
– volume: 345
  start-page: e7381
  year: 2012
  article-title: How to achieve international action on falsified and substandard medicines
  publication-title: BMJ
  doi: 10.1136/bmj.e7381
– volume: 88
  start-page: 247
  year: 2010
  article-title: Growing threat from counterfeit medicines
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.10.020410
– volume: 701
  start-page: 224
  year: 2011
  article-title: Impurity fingerprints for the identification of counterfeit medicines--a feasibility study
  publication-title: Anal Chim Acta
  doi: 10.1016/j.aca.2011.05.041
– volume: 9
  start-page: 45
  year: 2013
  article-title: Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
  publication-title: Global Health
  doi: 10.1186/1744-8603-9-45
– volume: 8
  start-page: 43
  year: 2013
  article-title: Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain
  publication-title: Curr Drug Saf
  doi: 10.2174/1574886311308010007
– volume: 130
  start-page: 122
  year: 2014
  article-title: Low-cost, high-speed identification of counterfeit antimalarial drugs on paper
  publication-title: Talanta
  doi: 10.1016/j.talanta.2014.05.050
– volume: 9
  start-page: e90601
  year: 2014
  article-title: Technologies for detecting falsified and substandard drugs in low and middle-income countries
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0090601
– article-title: Registro Sanitario de Productos Farmacéuticos—Base de datos online de productos
– volume: 14
  start-page: 597
  year: 2013
  article-title: Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated
  publication-title: EMBO Rep
  doi: 10.1038/embor.2013.82
– volume: 17
  start-page: 286
  year: 2013
  article-title: The need for coordinated action against falsified and substandard medicines
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.12.0988
– volume: 15
  start-page: 34
  year: 2014
  article-title: Microbiological contamination in counterfeit and unapproved drugs
  publication-title: BMC Pharmacol Toxicol
  doi: 10.1186/2050-6511-15-34
– article-title: Programmes—Essential medicines and health products
– volume: 7
  start-page: 216
  year: 2014
  article-title: The health and economic effects of counterfeit drugs
  publication-title: Am Health Drug Benefits
– article-title: ATC/DDD Índex 2014
– volume: 26
  start-page: 517
  year: 2009
  article-title: Simposio: Política de Medicamentos. LEY N.° 29459—ley de los productos farmacéuticos, dispositivos médicos y productos sanitarios
  publication-title: Rev Peru Med Exp Salud Pública
– ident: 2024051515233018000_6.4.e010387.48
  doi: 10.1016/j.chroma.2012.09.038
– volume: 38
  start-page: 141
  year: 2014
  ident: 2024051515233018000_6.4.e010387.35
  article-title: RFID in the pharmaceutical industry: addressing counterfeits with technology
  publication-title: J Med Syst
  doi: 10.1007/s10916-014-0141-y
– ident: 2024051515233018000_6.4.e010387.33
– ident: 2024051515233018000_6.4.e010387.53
  doi: 10.2174/1574886311308010007
– volume: 20
  start-page: 27
  year: 2014
  ident: 2024051515233018000_6.4.e010387.50
  article-title: Buying medicine online is risky business
  publication-title: Nurs N Z
– ident: 2024051515233018000_6.4.e010387.27
– ident: 2024051515233018000_6.4.e010387.41
  doi: 10.4269/ajtmh.13-0644
– volume: 1343
  start-page: 143
  year: 2014
  ident: 2024051515233018000_6.4.e010387.43
  article-title: A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products
  publication-title: J Chromatogr A
  doi: 10.1016/j.chroma.2014.03.078
– ident: 2024051515233018000_6.4.e010387.60
  doi: 10.1136/bmj.e7381
– ident: 2024051515233018000_6.4.e010387.39
  doi: 10.1016/j.aca.2011.05.041
– ident: 2024051515233018000_6.4.e010387.23
– ident: 2024051515233018000_6.4.e010387.3
– ident: 2024051515233018000_6.4.e010387.56
  doi: 10.17226/18272
– ident: 2024051515233018000_6.4.e010387.57
  doi: 10.1186/1741-7015-11-233
– volume: 19
  start-page: 286
  year: 2013
  ident: 2024051515233018000_6.4.e010387.55
  article-title: Legislations combating counterfeit drugs in Hong Kong
  publication-title: Hong Kong Med J
– ident: 2024051515233018000_6.4.e010387.18
– ident: 2024051515233018000_6.4.e010387.52
– volume: 7
  start-page: 216
  year: 2014
  ident: 2024051515233018000_6.4.e010387.7
  article-title: The health and economic effects of counterfeit drugs
  publication-title: Am Health Drug Benefits
– volume: 26
  start-page: 517
  year: 2009
  ident: 2024051515233018000_6.4.e010387.10
  article-title: Simposio: Política de Medicamentos. LEY N.° 29459—ley de los productos farmacéuticos, dispositivos médicos y productos sanitarios
  publication-title: Rev Peru Med Exp Salud Pública
– ident: 2024051515233018000_6.4.e010387.51
  doi: 10.1186/1744-8603-9-45
– ident: 2024051515233018000_6.4.e010387.26
  doi: 10.1136/bmjopen-2014-006088
– ident: 2024051515233018000_6.4.e010387.34
  doi: 10.1371/journal.pone.0090601
– volume: 106
  start-page: 73
  year: 2012
  ident: 2024051515233018000_6.4.e010387.37
  article-title: Technology for combating counterfeit medicine
  publication-title: Pathog Glob Health
  doi: 10.1179/204777312X13419245939485
– ident: 2024051515233018000_6.4.e010387.46
  doi: 10.1136/bmj.f2732
– volume: 52
  start-page: 195
  year: 2012
  ident: 2024051515233018000_6.4.e010387.28
  article-title: Role of the pharmacist in preventing distribution of counterfeit medications
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2012.11085
– ident: 2024051515233018000_6.4.e010387.24
– ident: 2024051515233018000_6.4.e010387.2
– ident: 2024051515233018000_6.4.e010387.4
  doi: 10.1016/j.jpba.2013.01.009
– ident: 2024051515233018000_6.4.e010387.47
  doi: 10.1093/chromsci/bmt006
– ident: 2024051515233018000_6.4.e010387.6
– ident: 2024051515233018000_6.4.e010387.20
– ident: 2024051515233018000_6.4.e010387.17
– ident: 2024051515233018000_6.4.e010387.30
– ident: 2024051515233018000_6.4.e010387.42
  doi: 10.1016/j.talanta.2014.05.050
– ident: 2024051515233018000_6.4.e010387.12
– ident: 2024051515233018000_6.4.e010387.9
– ident: 2024051515233018000_6.4.e010387.29
– ident: 2024051515233018000_6.4.e010387.49
  doi: 10.1016/j.chroma.2011.05.102
– volume: 15
  start-page: 34
  year: 2014
  ident: 2024051515233018000_6.4.e010387.13
  article-title: Microbiological contamination in counterfeit and unapproved drugs
  publication-title: BMC Pharmacol Toxicol
  doi: 10.1186/2050-6511-15-34
– volume: 17
  start-page: 286
  year: 2013
  ident: 2024051515233018000_6.4.e010387.59
  article-title: The need for coordinated action against falsified and substandard medicines
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.12.0988
– ident: 2024051515233018000_6.4.e010387.1
– ident: 2024051515233018000_6.4.e010387.21
– ident: 2024051515233018000_6.4.e010387.61
  doi: 10.1016/S2214-109X(14)70279-7
– ident: 2024051515233018000_6.4.e010387.54
– ident: 2024051515233018000_6.4.e010387.31
– ident: 2024051515233018000_6.4.e010387.16
– volume: 81
  start-page: 1
  year: 2013
  ident: 2024051515233018000_6.4.e010387.36
  article-title: Anti-counterfeit technologies: a pharmaceutical industry perspective
  publication-title: Sci Pharm
  doi: 10.3797/scipharm.1202-03
– ident: 2024051515233018000_6.4.e010387.58
  doi: 10.1038/embor.2013.82
– volume: 5
  start-page: 98
  year: 2013
  ident: 2024051515233018000_6.4.e010387.40
  article-title: Recent trends and future of pharmaceutical packaging technology
  publication-title: J Pharm Bioallied Sci
  doi: 10.4103/0975-7406.111820
– ident: 2024051515233018000_6.4.e010387.15
– ident: 2024051515233018000_6.4.e010387.32
– volume: 3
  start-page: pii: e002924
  year: 2013
  ident: 2024051515233018000_6.4.e010387.25
  article-title: Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-002924
– ident: 2024051515233018000_6.4.e010387.11
– ident: 2024051515233018000_6.4.e010387.14
  doi: 10.1111/bcp.12298
– volume: 83
  start-page: 209
  year: 2013
  ident: 2024051515233018000_6.4.e010387.45
  article-title: A multivariate-based wavenumber selection method for classifying medicines into authentic or counterfeitclasses
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2013.05.004
– volume: 88
  start-page: 247
  year: 2010
  ident: 2024051515233018000_6.4.e010387.5
  article-title: Growing threat from counterfeit medicines
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.10.020410
– volume: 85
  start-page: 1909
  year: 2011
  ident: 2024051515233018000_6.4.e010387.38
  article-title: Isotopic finger-printing of active pharmaceutical ingredients by 13C NMR and polarization transfer techniques as a tool to fight against counterfeiting
  publication-title: Talanta
  doi: 10.1016/j.talanta.2011.07.022
– ident: 2024051515233018000_6.4.e010387.22
– ident: 2024051515233018000_6.4.e010387.8
– ident: 2024051515233018000_6.4.e010387.19
– volume: 123
  start-page: 78
  year: 2014
  ident: 2024051515233018000_6.4.e010387.44
  article-title: Headspace-gas chromatographic fingerprints to discriminate and classify counterfeit medicines
  publication-title: Talanta
  doi: 10.1016/j.talanta.2014.01.020
SSID ssj0000459552
Score 2.1863554
SecondaryResourceType review_article
Snippet ObjectiveTo consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority...
To consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority over 18...
Objective To consolidate and assess information on counterfeit medicines subject to pharmaceutical alerts issued by the Peruvian Medicines Regulatory Authority...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e010387
SubjectTerms Alerts
counterfeit
Counterfeit Drugs
Counterfeiting
Drug dosages
Drug stores
Drugs
Falsified
Fraud - trends
Humans
Laboratories
Medical equipment
Medicine
Medicines
Peru
Pharmaceuticals
Public Health
Registration
Retrospective Studies
Safety
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RT9wwDI4mHtBeJhgbFNiUSZPGJCquSZo0vG0nEJp00x6GxFtVJ6k4BD109N75D_xDfgl22rvdTRPbwx6bJq1rO7Uj258Z-4g20DgpHbVvh1SZAtLKOZHikC8KZ62J8MWj7_rsXH27yC-WWn1RTlgHD9wx7kh541XwImTaKV94dIcH1mUSrABd2XhaR5u3dJiK_2CV2zwXPcxQJvUR3FxRPyrUioyy1Shqi-YER1cMUsTt_5Oz-XvO5JIROt1gr3rvkX_pqN5kL0Lzmq2P-vj4FhtSiTk1ng7jls_D5nd83PAfYTo75hWfhnY6mZdX8q5whR9QHsjj_QNSrT6_YeenJz-HZ2nfJiEF3G5tChU6RRa0gtyB1pDXWQa4U43VAAZEreu6FigAoyEELXydVUE6vDACjHfyLVtrJk3YYRyEcDnadAHoyclBBbauFMquFjZoUD5hB8ixslfzuzKeIKQue-aWxNyyY27CPtHU2w4z4_mZYi6A0vXA5NQf4_r5RYeLRf_0jq8k2cVUAtWOA6hqZa9q5d9ULWH7c734xQJ0cGRGjoBM2IfFbdyjFHipmjCZIZsI1JGg9FTCtjs1WlAizECpvMCHmxUFWyF19U4zvow44KoQVBa8-z--bY-9RHbpmJOk9tlaO52Fd-hutfA-7qwn-nIlww
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fi9QwEA96gggiev6rnhJB8ATLbZM0aXwRPTwO4cQHD_atdJJUV-7ac7f77nfwG_pJnGnTniuy-Ng03WbnT2aamfkNY8_RBhonpaP27ZAqU0BaOSdSHPJF4aw1PXzxyUd9fKo-zPN5PHBbxbTKcU_sN2rfOjojP0BDIjPacOWbi-8pdY2i6GpsoXGVXSPoMkrpMnMznbGgu2LzXESwoUzqAzj_Rl2pUDYyylmj2C0aFRzdMEs9ev-_XM6_Myf_MEVHt9mt6EPytwPT77Arodll109ilHyX3RzO4vhQYnSXHVLhObWjDouOj8H0FV80_FNYrl_zii9Dt2zHoks-lLPwfcoO-fXjJ_4L9fIeOz16__nwOI3NE1JAJexSqNBVsqAV5A60hrzOMkD9NVYDGBC1rutaIFuMhhC08HVWBenwwggw3sn7bKdpm_CQcRDC5WjpBaB_J2cV2LpSyNFa2KBB-YTtIwXLKPyrsv-ukLqMxC6J2OVA7IS9oKkXA5LG9pliZEjpIlw5dc042_7Qq-mh_3rHO-L0NJWgtvuBdvmljJpbKm-8Cl6ETDvlC4_fYzPrMglWgK7sLGF7o5xckuBSWhP2bLqNmkvhmKoJ7RrJRFCPBLCnEvZgEKtpJcLMlMoL_HGzIXAbS9280yy-9ujgqhBULPxo-7IesxtICN3nIKk9ttMt1-EJulcdPO116DelXiID
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ti9QwEB7OE0QQ0fOtekoEwRPsuU3TZCOInOJxCCt-cOG-lU6a6srZ1V4X9N87k6arK3eHH5uXNn1mppk0mWcAntAcaFyeO07fjqkyU0wr52RKRfV06qw1gb549kEfzdX74-J4C8asqBHA0zOXdpxPat6d7P_88es1GfyrmJHkBX77ylUk8IwPovGG7CW4TFOTYUudRX8_fJpVYYtCRvahc_oyP7CZKFUEqkhqsDFlBWb_s9zRf09V_jVNHd6A69G_FAeDQtyELd_uwJVZ3EHfgWvDfzoxhB_dggMOSudU1X7Ri3Gj_VQsWvHRd6uXohKd77vlGJAphlAXsRf4Vel11LPbMD989-ntURrTKqRI5tmnWJETZVErLBxqjUWTZUiWbaxGNCgb3TSNJIEZjd5rWTdZ5XNHF0aiqV1-B7bbZevvgUApXUFASyTPL59UaJtKkawbab1GVSewR_iVo1TLsOLIdRlRLxn1ckA9gafc9PvAsXFxSzmKo3SRyJzzaZxc3On5utN_PeMNy3ndlEm4Q8Gy-1xGmy5VbWrla-kz7VQ9rWmlNrEuy9FK1JWdJLA7askfCMghyjN2HPIEHq-ryaZ5o6Zq_XJFMDEJJFPvqQTuDkq1HsmomgmYDXXbGOpmTbv4EnjD1VRyGPH9c-_5AK4SBjocTFK7sN13K_-QfK4eHwU7-g16zSTA
  priority: 102
  providerName: Scholars Portal
Title Counterfeit medicines in Peru: a retrospective review (1997–2014)
URI https://bmjopen.bmj.com/content/6/4/e010387.full
http://bmjopen.bmj.com/content/6/4/e010387.full
https://www.ncbi.nlm.nih.gov/pubmed/27044580
https://www.proquest.com/docview/2663113033
https://www.proquest.com/docview/1779021194
https://pubmed.ncbi.nlm.nih.gov/PMC4823432
https://doaj.org/article/4d7d4ed2e16c4d8d82609c13b92b6a90
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFD7YFsQX8W60LhEEKxjcuWQm41u7tBYhpUgr61PImUxwRbOyzb77H_yH_hLPTLKxES19yZLJJDucC-dLzpzvALygGKitENa3b8dE6gyT0lqe0FCVZdYYHeiL8xN1fC7fz9P5pWL1cQafCfUGv33xjaRIncxvM_Pp1i3YCaws3qA_nQ2fVAidmDT02OFTKRMC6mnPM_Sf51A8odFRRArE_f9Cm39vmrwUhY7uwO0ePsb7nb7vwg3X3IObeZ8gvw8zX2PuO0-7RRtv8uYX8aKJT91q_TYu45VrV8tNfWXcVa7Ee34jyK8fP2nV8tUDOD86PJsdJ32fhATJ39oES0JFBpXE1KJSmNaMIbmqNgpRI69VXdecNKAVOqd4VbPSCUsnmqOurHgI282ycY8hRs5tSkGdI0E5MS3R1KUk5dXcOIWyimCPJFb0dn5RhFcIoYpeuIUXbtEJN4KXfur3jjTj6pl8o4DC9szkvkHG16tvej3cdK3_OPCaHaZ6Vu0wQKZW9E5ayEpX0lXcMWVllVX06jU1lgk0HFVpphHsbuzijwgI4QjmkYCI4PlwmZzUZ17Kxi3XJCbP6ui59GQEjzozGlbCNRlrmtHD9cjARksdX2kWnwMRuMy4rwt-cm1JP4VbdKbCziO5C9vtau2eEahqcQJbeq4nwaEmsLM_y_OP9HtweHL6YRI-VNDx3ZzRMZfZb8h-H7g
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFD4anQSTEILxVxhgJBCbRLTGduwECSE2NnVsrSa0SbsLOY4ziiAdaSvEHe_Ae_BQPAnH-RtFqOJml3GcxDn-fM6xzx_AE5KB2ghhXPl29KQO0UuM4R41pWFookiX6YsHQ9U_lm9PgpMl-NnEwji3yoYnlow6HRt3Rr5JgkT4juGKV2dfPFc1yllXmxIaFSz27bevtGWbvNx7Q_P7lPPdnaPtvldXFfCQ0Dn1MCEdIkIlMTCoFAaZ7yMBW0cKUSPPVJZlnMarFVqreJr5iRWGLjRHnRpB770Ey1LQVqYDy1s7w8N37akOKUhREPA6vZEv1CZ-_ujqYBEafecl56zFJMaodU4QlvUC_qXk_u2r-Yfw270O12qtlb2uYHYDlmy-CpcHtV1-Fa5Wp3-sCmq6Cdsu1N0VwLajKWvM9xM2ytmhLWYvWMIKOy3GTZgnqwJo2LrzR_n1_Qf9hdy4BccXQtjb0MnHub0LDDk3AekWHEmjFL0EoyyRhKGMR1ahTLuwThSM6-U2icudjFBxTezYETuuiN2FZ67rWZW7Y3FP3kxIbOoE6a5Ox6fFDz1vH_qvb2y5mW67uuTeZcO4OI1rXhHLVKfSptz6ysg0TGkH2IuMLzDiqJKo14W1BifnJDhfH1143N4mXuEMQEluxzMik0su6VL6yS7cqWDVjoTrnpRBSC_Xc4CbG-r8nXz0ocxHLkPuwpPvLR7WI7jSPxocxAd7w_37sEJEUaUHlFyDzrSY2Qek3E3xYb2iGLy_6EX8G0b5Yq4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bahQx9FArFEFE6221agTFCg67k2SSGUFEW5fW2tIHC_s2zslk7BadrXtBfPMf_Bs_xy_xnLlsXZHFlz5OJslkTs4tOTeARyQDrVPKcfl2DLSNMcickwE15XHsksRW6Yv3D8zOkX47iAYr8LONhWG3ypYnVow6Hzm-I--SIFEhM1zVLRq3iMPt_svTLwFXkGJLa1tOo0aRPf_tKx3fJi92t2mvH0vZf_N-aydoKgwESJg6DTAjfSJBozFyaAxGRRgiIblNDKJFWZiiKCSt3Rr03si8CDOvHD1YiTZ3iua9ABetikKmMTuw8_sdUpWSKJJNoqNQmS5-PuGKWISXIfvLsd2YBBq1LojEqnLAv9Tdv702_xCD_atwpdFfxasa4a7Bii_XYW2_sdCvw-X6HlDU4U3XYYuD3rkUth9ORWvIn4hhKQ79ePZcZGLsp-NRG_Ap6lAascmeKb--_6C_0E9vwNG5gPUmrJaj0t8GgVK6iLQMiaRbql6GSZFpwqZCJt6gzjuwSRBMG8KbpNWZRpm0AXbKwE5rYHfgCXc9rbN4LO8p2w1JXZMqnSt2fFo-6Nl80H994zXv9Lwrp_muGkbjj2nDNVKd21z7XPrQOJ3HOZ0Fe4kLFSYSTZb0OrDR4skZCM4opQMP56-Ja7ApKCv9aEZg4jSTnNxPd-BWjVbzlUjb0zqKaXK7gHALS118Uw6Pq8zkOpYcqHxn-bIewBqRbvpu92DvLlwimJjKFUpvwOp0PPP3SMub4v2KnAR8OG_6_Q3DQGV-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Counterfeit+medicines+in+Peru%3A+a+retrospective+review+%281997-2014%29&rft.jtitle=BMJ+open&rft.au=Medina%2C+Edwin&rft.au=Bel%2C+Elvira&rft.au=Su%C3%B1%C3%A9%2C+Josep+Mar%C3%ADa&rft.date=2016-04-04&rft.eissn=2044-6055&rft.volume=6&rft.issue=4&rft.spage=e010387&rft_id=info:doi/10.1136%2Fbmjopen-2015-010387&rft_id=info%3Apmid%2F27044580&rft.externalDocID=27044580
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon